Study Shows EpiCor Consumption Strengthens Immune Defense

Researchers found that intake of a 500-milligram dose of the EpiCor (EP) immunogen from Saccharomyces cerevisiae exhibits a fast and temporary effect on the flow and activation status of certain lymphocyte subsets and increases antioxidant protection. Researchers used a placebo-controlled randomized crossover study method to evaluate the 12 healthy adults selected as study subjects. Results showed that EP consumption raised the subjects' erythrocyte hematocrit levels, enhanced mucosal immune protection, reduced cold and flu symptoms, as well as seasonal allergy symptoms. Also, EP intake increased salivary secretion of immunoglobulin A.